[1]
S. Atchia, K. et al. 2019. Switching from a gonadotropin-releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis. Canadian Urological Association Journal. 14, 2 (Jul. 2019), 36–41. DOI:https://doi.org/10.5489/cuaj.5996.